Insider Profile
Rolstad, Chad
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Feb 16, 2023
Most Recent Trade
48
Credibility
Score
72%
Hit Rate
+2.4%
Avg 90d Return
+3.3%
Median 90d Return
29
Evaluated Trades
+13.6%
Best Trade
-9.8%
Worst Trade
Hit rate and returns are based on 29 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Cross-Company Track Record
67%
Hit Rate · 90d
+4.0%
Median Alpha · 90d
6
Closed Buys Evaluated
100%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 6 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Feb 16, 2023 $CP
Canadian Pacific Kansas City
— Other Sell 4,645 $140.98 $655K 80
Feb 02, 2023 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 177 $78.38 $14K 80
Feb 02, 2023 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 707 $75.17 $53K 80
Feb 02, 2023 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 12,028 — — 80
Feb 02, 2023 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 5,130 $79.29 $407K 80
Dec 31, 2022 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 1 $73.48 $73 80
Dec 06, 2022 $CP
Canadian Pacific Kansas City
— Open Market Buy 269 $78.81 $21K 80
Dec 02, 2022 $CP
Canadian Pacific Kansas City
— Open Market Buy 43 $74.17 $3K 80
Jun 03, 2022 $CP
Canadian Pacific Kansas City
— Open Market Buy 1,121 $74.85 $84K 80
Jun 03, 2022 $CP
Canadian Pacific Kansas City
— Open Market Buy 221 $74.83 $17K 80
Feb 08, 2022 $CP
Canadian Pacific Kansas City
— Other Sell 5,586 $145.12 $811K 80
Jan 31, 2022 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 485 $75.39 $37K 80
Jan 31, 2022 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 1,941 $72.13 $140K 80
Jan 31, 2022 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 15,001 — — 80
Jan 31, 2022 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 5,090 $71.40 $363K 80
Dec 31, 2021 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 33 $72.79 $2K 80
Dec 31, 2021 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 234 $73.52 $17K 80
Dec 31, 2021 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 339 $72.96 $25K 80
Dec 31, 2021 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 115 $72.79 $8K 80
Feb 05, 2021 $CP
Canadian Pacific Kansas City
— Other Sell 571 $670.78 $383K 80
Jan 29, 2021 $CP
Canadian Pacific Kansas City
— Expiry Buy 809 $336.22 $272K 80
Jan 29, 2021 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 2,264 — — 80
Jan 29, 2021 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 519 $354.46 $184K 80
Dec 31, 2020 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 4 $268.25 $1K 80
Dec 31, 2020 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 88 $273.93 $24K 80
Dec 31, 2020 $CP
Canadian Pacific Kansas City
— Plan / DRIP Buy 24 $268.25 $6K 80
Feb 07, 2020 $CP
Canadian Pacific Kansas City
— Other Sell 694 $472.87 $328K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Exercise Buy 655 $185.85 $122K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Open Market Buy 792 $266.87 $211K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Exercise Buy 792 $155.45 $123K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Exercise Sell 655 $185.85 $122K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 2,718 — — 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Comp. Grant Buy 906 $265.81 $241K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Open Market Buy 655 $265.62 $174K 80
Jan 31, 2020 $CP
Canadian Pacific Kansas City
— Exercise Sell 792 $155.45 $123K 80
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.